Vinati Organics
Vinati Organics Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
Vinati Organics projects a 20% CAGR in revenue over the next three years. Vinati Organics projects a 20% CAGR in revenue over the next 3 years, driven by leadership in ATBS, steady butyl phenol performance, and strong antioxidants growth.
From Vinati Organics's Q4 FY25 earnings-call transcript · updated 26 Aug 2026.
Revenue & Sales Performance
- Vinati Organics projects a 20% CAGR in revenue over the next three years.
- Continued robust growth expected in ATBS driven by volume expansion and rising demand from oil recovery and water treatment.
- Antioxidants (AO) business to see strong momentum with capacity utilization expected to increase from ~50% to 90% over two years.
- Butyl phenols anticipated to grow steadily, with FY26 revenue expected between INR800-850 crores from antioxidants alone.
- VOPL (Veeral Organic) subsidiary aims for ~INR100 crores revenue in FY26, ramping up product commercialization.
- New products under development (anisole derivatives, 4-MAP, TAA, PTAP) to diversify portfolio and fuel growth.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Vinati Organics said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- FY'25 capex was approx INR400 crores, focused on capacity enhancements, new products, and operational scalability including investments in Vinati Organic Products Limited (VOPL).
- ATBS capacity expansion scheduled for completion by June 2025, increasing capacity by about 25-30% in Phase 1, followed by a second phase a year later. Total Brownfield capex for ATBS expansion budgeted at INR300 crores.
- VOPL capex total INR500 crores; about INR250 crores done, balance pending. Products including MEHQ, Guaiacol, TAA, PTAP, Anisole, and 4-Methoxy Acetophenone will be commercialized.
- FY'26 capex marked at approx INR360 crores to continue expansion, innovation, and operational efficiency.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Vinati Organics said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company is currently oversold in the ATBS segment.
- There is a backlog of pending orders for ATBS.
- The new capacity coming in Phase 1 of the ATBS expansion is expected to be filled immediately upon commissioning due to the existing order book.
2 more points management made on order book & pipeline
Vinati Organics — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹611 Cr, net profit ₹138 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Vinati Organics Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Fine Organic Industries Ltd (Q4 FY25)
Domestic demand is growing strongly at around 8-10% CAGR, higher than the global average of 5-6%. Key concall takeaways from Fine Organic Industries Ltd's Q4…
- Rossari Biotech Ltd (Q4 FY25)
Consumer and Institutional businesses grew 67% YoY to Rs. Key concall takeaways from Rossari Biotech Ltd's Q4 FY25 earnings call — and how it ranks against…
- Solar Industries (Q4 FY25)
For FY '26, Solar Industries is confident of crossing INR 10,000 crores in revenue. Key concall takeaways from Solar Industries India Ltd's Q4 FY25 earnings…
- Asahi Songwon Colors Ltd (Q4 FY25)
AZO segment capacity utilization to improve from 64% to around 80-85%, with top line growth from ₹70 crores to ₹90 crores (~26-27% growth) (Page 16). Key…
Frequently Asked Questions
What were Vinati Organics Q4 FY25 results?
Vinati Organics projects a 20% CAGR in revenue over the next three years. Vinati Organics projects a 20% CAGR in revenue over the next 3 years, driven by leadership in ATBS, steady butyl phenol performance, and strong antioxidants growth.
What is Vinati Organics share price analysis?
Vinati Organics currently shows a neutral. The stock trades at a P/E of 27.6 with a market cap of ₹13,781 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vinati Organics planning capital expenditure?
FY'25 capex was approx INR400 crores, focused on capacity enhancements, new products, and operational scalability including investments in Vinati Organic Products Limited (VOPL). - ATBS capacity expansion scheduled for completion by June 2025, increasing capacity by about 25-30% in Phase 1, followed by a second phase a year later.
Keep Vinati Organics on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.